In<unk>  patients with<unk><unk> , the findings of abrupt loss of conduction over a manifest pathway during exercise testing in sinus rhythm or intermittent loss of<unk><unk>  during ECG or ambulatory monitoring are useful to identify patients at low risk of rapid conduction over the pathway. An EP study is reasonable in<unk>  patients with<unk><unk>  to risk-stratify for arrhythmic events. Catheter ablation of the accessory pathway is reasonable in<unk>  patients with<unk><unk>  if an EP study identifies a high risk of arrhythmic events, including rapidly conducting<unk> -excited AF.
Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation
Supraventricular tachycardia AHA recommendations for Management of Symptomatic Patients With Manifest Accessory Pathways
Supraventricular tachycardia AHA recommendations for Management of AVNRT
Supraventricular tachycardia AHA recommendations for Management of Orthodromic AVRT
Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia
Supraventricular tachycardia AHA recommendations for Management of IST
Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia
Supraventricular tachycardia AHA recommendations for Management of Atrial Flutter